INTERNATIONAL PATENT: NGM BIOPHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING NAUSEA AND VOMITING DISORDERS USING ANTI-GFRAL ANTIBODIES"

GENEVA, Feb. 12 -- NGM BIOPHARMACEUTICALS, INC. (333 Oyster Point BoulevardSouth San Francisco, California 94080) filed a patent application (PCT/US2024/040113) for "METHODS OF TREATING NAUSEA AND VOMITING DISORDERS USING ANTI-GFRAL ANTIBODIES" on Jul 30, 2024. With publication no. WO/2025/029768, the details related to the patent application was published on Feb 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEPAOLI, Alexander M. (333 Oyster Point BoulevardSouth San Francisco, California 94080), HENSCHEL, Carroll E. (333 Oyster Point BoulevardSouth San Francisco, California 94080), HSU...